title: Effect of calcitonin on gastric emptying and on postprandial gastrin and insulin release in patients with type I gastric ulcer.
abstract: In a double-blind placebo-controlled study, the effect of calcitonin on gastric emptying and on serum concentrations of gastrin, insulin, glucose, calcium and phosphorus after a mixed solid-liquid meal was examined in six patients with type I gastric ulcer. Synthetic salmon calcitonin 415 pmol i.v. was given as a bolus followed by a 90-min infusion to reach an overall dose of 62.25 pmol.kg-1. Gastric emptying of a radiolabelled meal was measured with a gamma camera. Calcitonin suppressed gastric emptying in all patients examined. The mean gastric transit time, MTT90, increased from 38.1 +/- 0.4 min after placebo to 43.1 +/- 0.6 min after calcitonin (P less than 0.001). Calcitonin significantly blunted the postprandial gastrin release: AUC0-90 10,398 +/- 2886 ng. l-1 min (placebo) and 8238 +/- 2573 ng. l-1 min (calcitonin), P less than 0.05, and abolished the postprandial insulin release--AUC0-90 2244 +/- 230 mU.l-1 min (placebo) vs. 638 +/- 198 mU.l-1 min (calcitonin), P less than 0.01. A steady increase in the serum glucose during calcitonin infusion, reaching up to 5.6 +/- 0.31 mmol.l-1 at the end of the infusion, was observed. Calcitonin did not significantly affect serum calcium or phosphorus concentrations. The authors conclude that a delayed gastric emptying is to be expected in patients undergoing calcitonin treatment.
authors.affiliation: Fourth Department of Internal Diseases, Silesian School of Medicine, Katowice, Poland.
authors.forename: G
authors.initials: G
authors.lastname: Jonderko
authors.forename: K
authors.initials: K
authors.lastname: Jonderko
authors.forename: T
authors.initials: T
authors.lastname: Gołab
mesh_terms: D000328:Adult; D000368:Aged; D002116:Calcitonin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D004311:Double-Blind Method; D004435:Eating; D005746:Gastric Emptying / Q000187:drug effects*; D005755:Gastrins / Q000097:blood / Q000187:drug effects*; D006801:Humans; D007328:Insulin / Q000097:blood*; D008297:Male; D008875:Middle Aged; D013276:Stomach Ulcer / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D005755:Gastrins; D007328:Insulin; D002116:Calcitonin